1 McNeal-Davidson A, "The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976" 34 : 170-178, 2013
2 Sunagawa K, "Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease" 29 : 1115-1119, 2008
3 Panzer J, "Rupture of giant coronary arterial aneurysm without progressive dilation" 18 : 189-190, 2008
4 Suzuki N, "Rupture of coronary aneurysm in Kawasaki disease" 41 : 318-320, 1999
5 Ohkubo T, "Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations" 1-7, 2007
6 Hashino K, "Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy" 43 : 211-217, 2001
7 Suda K, "Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease" 73 : 1319-1323, 2009
8 Kato H, "Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients" 94 : 1379-1385, 1996
9 Burns JC, "Kawasaki syndrome" 364 : 533-544, 2004
10 Kato H, "Kawasaki disease: effect of treatment on coronary artery involvement" 63 : 175-179, 1979
1 McNeal-Davidson A, "The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976" 34 : 170-178, 2013
2 Sunagawa K, "Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease" 29 : 1115-1119, 2008
3 Panzer J, "Rupture of giant coronary arterial aneurysm without progressive dilation" 18 : 189-190, 2008
4 Suzuki N, "Rupture of coronary aneurysm in Kawasaki disease" 41 : 318-320, 1999
5 Ohkubo T, "Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations" 1-7, 2007
6 Hashino K, "Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy" 43 : 211-217, 2001
7 Suda K, "Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease" 73 : 1319-1323, 2009
8 Kato H, "Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients" 94 : 1379-1385, 1996
9 Burns JC, "Kawasaki syndrome" 364 : 533-544, 2004
10 Kato H, "Kawasaki disease: effect of treatment on coronary artery involvement" 63 : 175-179, 1979
11 Burns JC, "Kawasaki disease: a brief history" 106 : E27-, 2000
12 Chen S, "Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis" 99 : 76-82, 2013
13 Kato H, "Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction" 33 : 27-35, 1991
14 Kuramochi Y, "Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease" 42 : 470-475, 2000
15 Uehara R, "Epidemiology of Kawasaki disease in Asia, Europe, and the United States" 22 : 79-85, 2012
16 Kobayashi T, "Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial" 379 : 1613-1620, 2012
17 Imai Y, "A fatal case of ruptured giant coronary artery aneurysm" 165 : 130-133, 2006